Barclays PLC acquired a new position in TruBridge, Inc. (NASDAQ:TBRG – Free Report) in the third quarter, HoldingsChannel reports. The fund acquired 12,559 shares of the company’s stock, valued at approximately $150,000.
A number of other hedge funds also recently added to or reduced their stakes in the business. Geode Capital Management LLC purchased a new stake in TruBridge in the third quarter worth about $1,747,000. XTX Topco Ltd purchased a new stake in TruBridge in the third quarter worth about $154,000. Jane Street Group LLC purchased a new stake in TruBridge in the third quarter worth about $400,000. State Street Corp purchased a new stake in TruBridge in the third quarter worth about $829,000. Finally, SageView Advisory Group LLC purchased a new stake in shares of TruBridge during the third quarter valued at about $664,000. 88.64% of the stock is owned by hedge funds and other institutional investors.
TruBridge Price Performance
TruBridge stock opened at $22.92 on Thursday. TruBridge, Inc. has a 1 year low of $7.55 and a 1 year high of $23.64. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.78 and a current ratio of 1.80. The company’s fifty day moving average price is $19.07 and its 200 day moving average price is $14.57. The stock has a market capitalization of $342.20 million, a P/E ratio of -5.60, a P/E/G ratio of 4.41 and a beta of 0.67.
Insider Activity at TruBridge
In other TruBridge news, Director Mark V. Anquillare purchased 2,500 shares of the business’s stock in a transaction on Monday, November 25th. The shares were bought at an average cost of $16.81 per share, for a total transaction of $42,025.00. Following the completion of the purchase, the director now directly owns 17,178 shares of the company’s stock, valued at approximately $288,762.18. This trade represents a 17.03 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on TBRG. Stephens upped their price objective on shares of TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a report on Wednesday, November 20th. Barclays upped their price objective on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $13.00 price objective on shares of TruBridge in a report on Friday, October 4th.
View Our Latest Stock Report on TruBridge
About TruBridge
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Recommended Stories
- Five stocks we like better than TruBridge
- What is a Dividend King?
- Oracle Announces Game-Changing News for the AI Industry
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Capture the Benefits of Dividend Increases
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding TBRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TruBridge, Inc. (NASDAQ:TBRG – Free Report).
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.